Thus, as a tumor promoter, TGF‐β stimulates both Smad and non‐Smad signaling (termed tumor promoter signaling), leading to epithelial mesenchymal transition (EMT), autoinduction, invasiveness, and chemoresistance in these cancer cells. Here, TGFB1 is linked to cancer.